
kegg
The first fertility tracking kegel device to help pinpoint fertile window and ovulation up to 7 days in advance.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor investor investor | €0.0 | round | |
* | $6.5m | Series A | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | - | 72 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
kegg is a company that operates in the FemTech market, specializing in fertility tracking solutions. The company's flagship product is a 2-in-1 device that functions as both a fertility tracker and a kegel ball. This device is designed to help women identify their fertile window by analyzing cervical mucus, which is a key indicator of fertility. The product is aimed at women who are trying to conceive and want a more accurate and personalized method of tracking their fertility.
The business model is based on the one-time sale of the kegg device, with no recurring subscriptions for its core features. The company also offers a money-back guarantee if a user does not get pregnant within a year of using the device. kegg primarily serves individual consumers and has a global reach, with sales in multiple countries. The company leverages online channels for sales and marketing, including its own website and social media platforms.
Keywords: fertility tracker, FemTech, cervical mucus, reproductive health, medical device, consumer electronics, e-commerce, direct-to-consumer, health technology, women's health